Bruker today announces a collaboration between Bruker and Nextval for high-throughput screening of drugs and their metabolites using Bruker’s ultrafleXtreme MALDI-TOF/TOF in conjunction with Nextval’s MassInsight technology.
ultrafleXtreme MALDI-TOF/TOF system (Photo: Business Wire)
The ultrafleXtreme mass spectrometer combines the acquisition speed of its 2 kHz smartbeam II TM laser with its Perpetual Ion Source for unrivalled productivity, ensuring optimum performance for low concentration high-throughput screening. The versatility of Bruker’s Compass TM software allows integration with Nextval’s screening technology to maximize sample density and reduce sample analysis costs.
Nextval’s MassInsight screening technology is based on novel surface chemistries coupled with unique microarray acoustic deposition methods (EDC Biosystems & BioSero LLC) that address critical needs in several industries including the pharmaceutical, testing and industrial markets.
Dr. Matthew Greving, CSO of Nextval, stated: “The ultrafleXtreme is an invaluable tool for Nextval because it combines the sensitivity and throughput needed for our MassInsight customers, enabling fast accurate screening of potential drug candidates and enzyme activity.” Nextval recently has been awarded a Phase II SBIR grant to further develop and commercialize their MassInsight technology for high-throughput enzyme assays.Dr. Paul Speir, Senior Vice President of Bruker Daltonics stated: “We are excited by the combination of Nextval’s MassInsight technology with the information rich, high throughput capabilities provided by the ultrafleXtreme. Moreover, we are pleased to support Nextval in their efforts to develop this important technology for the rapid and economical screening of drug candidates.” About Bruker Corporation Bruker Corporation (NASDAQ: BRKR) is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analysis. For more information, please visit www.bruker.com. Follow Us On: About Nextval Corporation Nextval, Inc. is a company developing next generation high-throughput high-content mass based screening assays. For more information please visit www.nextval.com. Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50439924&lang=en
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV